机器人挽救性腹膜后及盆腔淋巴结清扫术治疗「仅淋巴结」复发前列腺癌:技术与初步系列
本文描述机器人辅助高位扩大挽救性腹膜后及盆腔淋巴结清扫术(sRPLND+PLND)治疗「仅淋巴结」复发前列腺癌的技术。10例患者于2015年9月至2016年3月接受该手术,淋巴结检出数优于开放手术且并发症减少。结论认为需要更长随访评估肿瘤学结局。
要点
- 机器人辅助sRPLND+PLND可用于「仅淋巴结」复发前列腺癌的挽救性治疗。
- 每例患者平均检出淋巴结83枚(范围41-132),7例(70%)最终病理淋巴结阳性。
- 淋巴结阳性患者术后2个月中位PSA下降83%,但需更长随访评估肿瘤学结局。
核心结论
- 本文呈现了机器人辅助sRPLND+PLND的初步系列,复现开放手术并获得更优的淋巴结检出数和降低的并发症。
- 本文呈现了达肾血管水平的解剖性淋巴结清扫模板的机器人辅助技术细节。
- 需要更长随访以评估肿瘤学结局。
研究设计与样本
- 单臂初步系列,10例「仅淋巴结」复发前列腺癌患者于2015年9月至2016年3月接受机器人辅助sRPLND+PLND。
- 复发淋巴结由11C-乙酸盐正电子发射断层扫描/计算机断层扫描(PET/CT)成像识别。
- 解剖模板头侧自双侧肾动脉/肾静脉至尾侧Cloquet淋巴结,完整切除主动脉-腔静脉及髂血管树的淋巴脂肪组织;RPLND先于PLND。
- 术中在四个前瞻性设定的解剖区域进行细致淋巴结定位。
主要发现
- 中位手术时间4.8小时,估计失血量100 mL,住院时间1天。
- 无患者发生术中并发症、中转开放或输血;3例患者发生可自行缓解的Clavien-Dindo II级术后并发症。
- 每例患者平均检出淋巴结83枚(范围41-132),平均阳性淋巴结23枚(范围0-109);7例(70%)最终病理淋巴结阳性。
- 解剖水平I、II、III、IV的淋巴结阳性率分别为28%、32%、33%和33%。
- 在淋巴结阳性患者中,术后2个月随访时中位PSA水平下降83%。
局限性
- 原文结论指出需要更长随访以评估肿瘤学结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To describe the technique of robot-assisted high-extended salvage retroperitoneal and pelvic lymphadenectomy (sRPLND+PLND) for 'node-only' recurrent prostate cancer. PATIENTS AND METHODS: In all, 10 patients underwent robot-assisted sRPLND+PLND (09/2015-03/2016) for 'node-only' recurrent prostate cancer, as identified by 11 C-acetate positron emission tomography/computed tomography imaging. Our anatomical template extends from bilateral renal artery/vein cranially up to Cloquet's node caudally, completely excising lymphatic-fatty tissue from aorto-caval and iliac vascular trees; RPLND precedes PLND. Meticulous node-mapping assessed nodes at four prospectively assigned anatomical zones. RESULTS: The median operative time was 4.8 h, estimated blood loss 100 mL and hospital stay 1 day. No patient had an intraoperative complication, open conversion or blood transfusion. Three patients had spontaneously resolving Clavien-Dindo grade II postoperative complications. The mean (range) number of nodes excised per patient was 83 (41-132) and mean (range) number of positive nodes per patient was 23 (0-109). Seven patients (70%) had positive nodes on final pathology. Node-positive rates per anatomical level I, II, III and IV were 28%, 32%, 33% and 33%, respectively. In patients with positive nodes, the median PSA level had decreased by 83% at the 2-month follow-up. CONCLUSION: The initial series of robot-assisted sRPLND+PLND is presented, wherein we duplicate open surgery with superior nodal counts and decreased morbidity. Robot-assisted technical details for an anatomical LND template up to the renal vessels are presented. Longer follow-up is necessary to assess oncological outcomes.
引用
- Abreu A, Fay C, Park D, et al. Robotic salvage retroperitoneal and pelvic lymph node dissection for 'node-only' recurrent prostate cancer: technique and initial series. BJU Int. 2017. PMID: 27981731. doi:10.1111/bju.13741
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。